Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GM all..SAPX
SAPX.. Solid ticker to watch today
GM -KR..APS E-Mail Out this am
Hi Everyone,
As announced yesterday our new pick is $PRTN and it is already doing phenomenal for our members. We do know that many of you are still on vacation (including most of wallstreet), and are not trading until the beginning of September.
That's in fact where the fancy term September Rally comes from. September has historically been huge for the markets, and we think that PRTN will also benefit from a huge uptrend throughout the month, and that uptrend begins now.
Premium Members had the opportunity to come in at the market open yesterday and have already secured gains of about 50% (so for next time if you would like the same opportunity head over to PremiumStockReport dot com and sign up now).
That being said PRTN still offers ridiculous upside potential for our members as it is still trading at just 35 cents and none of our biotech picks has ever produced less than 1,000%
In fact our most recent pick in the pharmaceuticals industry soared from an initial price of about 30 cents to well over $2 within a 8-week time period.
PRTN confirmed the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.
Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.
The drug indication, that Eaton Scientific named Tropine 3, is currently being prescribed and compounded by doctors in the Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment. The drug, homatropine, is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, and as a mydriatic in order to dilate the pupil. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic administration.
Tropine 3 has been shown in individual cases to reduce the symptoms of hot flashes in terms of intensity, duration, and number of occurrences without the use of dangerous hormones which," said Michael Borkowski, CEO and President of Eaton Scientific Systems, Ltd. "We look forward to building market awareness and acceptance of Tropine 3 throughout the women's health care sector in hopes of improving the lives of the over 50 million women in America that would benefit from this proven safe and effective treatment for hot flashes."
The Company is currently assembling a senior management team and group of scientific advisors to assist in the ongoing development and clinical testing of Tropine 3. Clinical trials currently being contemplated will be performed to strict FDA standards to provide support to claims made in Eaton Scientific's patent filed under USPTO #60/719,756. Additional information regarding the near-term scheduling and commencement of planned Tropine 3 clinical trials will be made available in subsequent public statements.
You can visit the company's site at EatonScientific dot com
We plan on covering PRTN for a while as we follow the company's progress on FDA clinical trials for Tropine 3.
Pharmaceutical stocks always soar after the FDA approves a drug in the pipeline and PRTN could do the same should clinical trials of Tropine 3 be successful and the FDA approves it.
In fact we saw a "pennystock" (on pinksheet) soar more than 2,000% in a single day after the FDA approved one of its drugs. The company was TTNP it went from 3 cents to more than $2 about 36 months ago. It soared in less than 30 days. and is still sitting at around $1 even today!
That's the type of enormous positive effect an FDA approval can have on a stock as it creates millionaires virtually overnight.
Watch PRTN very closely over the next few weeks as it is officially our most anticipated alert of the (end of) summer!
Happy Trading!
Your AwesomePennyStocks Editor.
APS E-Mail Out
Hi Everyone,
As announced yesterday our new pick is PRTN and it is already doing phenomenal for our members. We do know that many of you are still on vacation (including most of wallstreet), and are not trading until the beginning of September.
That's in fact where the fancy term September Rally comes from. September has historically been huge for the markets, and we think that PRTN will also benefit from a huge uptrend throughout the month, and that uptrend begins now.
Premium Members had the opportunity to come in at the market open yesterday and have already secured gains of about 50% (so for next time if you would like the same opportunity head over to PremiumStockReport dot com and sign up now).
That being said PRTN still offers ridiculous upside potential for our members as it is still trading at just 35 cents and none of our biotech picks has ever produced less than 1,000%
In fact our most recent pick in the pharmaceuticals industry soared from an initial price of about 30 cents to well over $2 within a 8-week time period.
PRTN confirmed the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.
Eaton Scientific has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.
The drug indication, that Eaton Scientific named Tropine 3, is currently being prescribed and compounded by doctors in the Los Angeles, California specifically for their patients who have hot flash symptoms and do not want to take hormonal treatment. The drug, homatropine, is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, and as a mydriatic in order to dilate the pupil. Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic administration.
Tropine 3 has been shown in individual cases to reduce the symptoms of hot flashes in terms of intensity, duration, and number of occurrences without the use of dangerous hormones which," said Michael Borkowski, CEO and President of Eaton Scientific Systems, Ltd. "We look forward to building market awareness and acceptance of Tropine 3 throughout the women's health care sector in hopes of improving the lives of the over 50 million women in America that would benefit from this proven safe and effective treatment for hot flashes."
The Company is currently assembling a senior management team and group of scientific advisors to assist in the ongoing development and clinical testing of Tropine 3. Clinical trials currently being contemplated will be performed to strict FDA standards to provide support to claims made in Eaton Scientific's patent filed under USPTO #60/719,756. Additional information regarding the near-term scheduling and commencement of planned Tropine 3 clinical trials will be made available in subsequent public statements.
You can visit the company's site at EatonScientific dot com
We plan on covering PRTN for a while as we follow the company's progress on FDA clinical trials for Tropine 3.
Pharmaceutical stocks always soar after the FDA approves a drug in the pipeline and PRTN could do the same should clinical trials of Tropine 3 be successful and the FDA approves it.
In fact we saw a "pennystock" (on pinksheet) soar more than 2,000% in a single day after the FDA approved one of its drugs. The company was TTNP it went from 3 cents to more than $2 about 36 months ago. It soared in less than 30 days. and is still sitting at around $1 even today!
That's the type of enormous positive effect an FDA approval can have on a stock as it creates millionaires virtually overnight.
Watch PRTN very closely over the next few weeks as it is officially our most anticipated alert of the (end of) summer!
Happy Trading!
Your AwesomePennyStocks Editor.
Additional $PRTN Alerts
BlueChipStocks
http://www.bluechipstockpick.com/stock-picks.php
PennyStockPicks
http://www.thepennystockpicks.com/wildcard-play-prtn-2/
DailyPennyPicks
http://natrader.blogspot.com/2012/08/pristine-solutions-inc-common-prtn.html
GuerillaStockTrading
http://guerillastocktrading.com/penny-stock-newsletter-watch/?s=prtn
StockMarketWatch
http://www2.thestockmarketwatch.com/newsletters/2012/08/28/will-you-miss-out-2500-people-opened-this-email/
PennyStockAlerts
http://pennystockalerts.com/wildcard-play-prtn-stock/
DailyPennyPicks PRTN 8/7
http://natrader.blogspot.com/2012/08/pristine-solutions-inc-common-prtn.html
BlueChipStocks PRTN 12:44 am
2.3mm subscribers
http://www.bluechipstockpick.com/stock-picks.php
BlueChipStocks PRTN 12:44 am
2.3mm subscribers
http://www.bluechipstockpick.com/stock-picks.php
UCHC is running thin and
a good one to watch. Looks like SDVI has turned the corner to fill the 0005 gap.
Nice call from you yesterday @ .008..BBDA
Lets see if they follow up in the old APS fashion.
PRTN Rolling the dice..in @ .384
LGBS - DD Sheet
Legends Business Group, Inc.
Currently the company’s newly launched division, Legends Power, has focused its mission to look for, test and acquire alternative and exotic energy products and technology and bring them into the marketplace.
Legends will provide advice in the key elements required to be successful in the alternative energy industry. Whether a company has only a concept on a sketching pad or is in full production and distribution of products, Legends can help to complete their ideas or expand their capabilities by providing their specialized consulting in this constantly evolving industry.
Rodolfo Sablon - President and Chief Executive Officer
“This is an exceptional opportunity not only to create shareholder equity but to do so while helping save our planet,” said Rodolfo Sablon. “Environmental sustainability and independence from fossil fuels should be a primary goal of every American. Legends presents an outstanding platform to participate in that effort.”
Rodolfo Sablon is an altruistic entrepreneur with a Bachelor in Science from Florida International University. Rodolfo serves as a director for The Motivational Edge as well as ventured into his entrepreneurial endeavors, becoming CEO and Founder of APEX Tutoring. As a result of his leadership and direction, APEX Tutoring has flourished and he now has a franchise with operations expanding into four other states. Among other things Rodolfo is also an expert grant-writing specialist. During his career Rodolfo Sablon has written many grant proposals for non-profit organizations and has been instrumental in the implementation of various worthwhile projects.
Recent Projects
http://www.legendspower.com/current_projects.php
Products
http://www.legendspower.com/products.php
Share Structure
SS -Explained
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78705516
>doogdilinger
Quarterly Report - Aug 20, 2012
http://www.otcmarkets.com/financialReportViewer?symbol=LGBS&id=88779
Recent News
LEGENDS APPLIES FOR ITS FIRST U.S. PATENT - Aug 22, 2012
http://www.otcmarkets.com/stock/LGBS/news/LEGENDS-APPLIES-FOR-ITS-FIRST-U-S--PATENT?id=51614&b=y
LEGENDS REVEALS ZOMBIE CHARGERS - Aug 15, 2012
http://www.otcmarkets.com/stock/LGBS/news/LEGENDS-REVEALS-ZOMBIE-CHARGERS-AS-THE-NAME-FOR-ITS-NEW-PRODUCT-LINE?id=51325&b=y
LEGENDS EXPERIMENTS WITH CHARGER CONTROLLER - Aug 07, 2012
http://www.otcmarkets.com/stock/LGBS/news/LEGENDS-EXPERIMENTS-WITH-CHARGER-CONTROLLER--OPERATES-GOLF-CART-USING-ONLY-SOLAR-POWER-FOR-SIX-MONTHS?id=50923&b=y
LEGENDS RETAINS AUDITOR; TO REGAIN ITS SEC FULLY REPORTING STATUS - Jul 24, 2012
http://www.otcmarkets.com/stock/LGBS/news/LEGENDS-RETAINS-AUDITOR--PREPARING-TO-REGAIN-ITS-SEC-FULLY-REPORTING-STATUS?id=50492&b=y
LEGENDS EXECUTES LETTER OF INTENT; ACQUIRES NEW TYPE OF BATTERY CHARGING DEVICE - Jul 17, 2012
http://www.otcmarkets.com/stock/LGBS/news/LEGENDS-EXECUTES-LETTER-OF-INTENT--ACQUIRES-NEW-TYPE-OF-BATTERY-CHARGING-DEVICE?id=50128&b=y
Company Website - http://www.legendspower.com/
Checking In..Could get busy mañana
LGBS
Waiting for the dip thru the 11's
BLVT
T53 "You might consider a position in?"-We need a runner :)
BLVT had a nice intraday bounce
off .0010
MEXP was thinning till a 65mil dump hit trip 1's today.
They immediately jumped on the ask. Kinda ruined the play lol
Probably not a Pink for long.
Flagged from a scan..Interesting-BM#4
Little Buzzz going on w/ IFIX
#7 BM
And I thought I had heard it all..
Who did make that decision bro?
Nice close on GYST..held up well
after trading lower w/ out APS alert. Good one to watch for volume.